The Gulliver syndrome: a conceptual framework to address therapeutic inertia in patients with borderline cardiovascular risk profiles
We propose a novel clinical construct, the "Gulliver syndrome", to describe the scenario in which multiple, mildly elevated cardiovascular risk factors (CVRFs) coexist within an individual and together result in a significantly heightened overall risk of cardiovascular disease (CVD). This accumulation of small deviations, often dismissed in clinical practice, can exert a synergistic impact on vascular health. Our aim is to formalize this underrecognized phenotype, which falls outside traditional diagnostic entities such as the metabolic syndrome, and to provide a framework that enables early recognition and management. We outline proposed diagnostic criteria, contrast this syndrome with related constructs, support its clinical relevance with emerging literature, and present a representative case. Ultimately, we advocate for this framework as a tool to overcome therapeutic inertia and encourage proactive, multifactorial interventions in primary and preventive care.
Authors
- José Abellán-Huerta (ORCID: https://orcid.org/0000-0002-2189-7430)
- José Abellán-Alemán
- José Francisco López-Gil
Institutions
- Universidad Espíritu Santo (EC)
- Santa Lucía University General Hospital (ES)
- Universidad de Los Lagos (CL)
- Universidad Católica de Murcia (ES)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-08-14
- DOI
- https://doi.org/10.3389/fcvm.2025.1652447
- Primary Topic
- Genetic Associations and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00